Sales down Again, nothing positive of substance in ann.,2 quarters before money runs out so probably they will have to attempt a capital raise within 3 months, such a bright star when it listed, v.poor management, until FDA make changes its in an incredibly competitive area and is way too top heavy.
Add to My Watchlist
What is My Watchlist?
